A biennial fecal immunochemical test-based CRC screening program can increase early-stage CRC detection and short-term survival.

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

A new study suggests that everyday processed foods may play a bigger role in early colorectal changes than previously thought ...

Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...

One study found that vitamin D may have anticancer effects, which could help reduce colorectal cancer risk. Another piece of ...

NUS Medicine-led study shows extracellular vesicles carrying gene-targeting antisense oligonucleotides (ASOs) and immune ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...